Stay updated with breaking news from Adjunct Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study...
Tongxinluo, a compound made from extracts of plants and insects, has been in use in Chinese medicine for treating heart attacks.
/PRNewswire/ -- Bleeding disorders are typically hereditary, with common symptoms encompassing easy bruising, frequent nosebleeds, heavy menstrual bleeding,...
New Delhi [India], June 1 (ANI): The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.
Pic credit: ANI NEW DELHI: The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-Covid drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings. The DRDO said that anti-Covid drug 2DG can now be given to Covid 19 patients under the care and prescription of doctors. DRDO also issued some important guidelines with regard to its anti-Covid -19 drug. "Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe Covid patients for a maximum...